cMET Avimer polypeptides (MedImmmue)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamecMET Avimer polypeptides (MedImmmue)
Drug Alias NamecMET-targeting anticancer avimers (MedImmune)cMET-targeting avimers (Avidia/MedImmune)MEDI-555
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHepatocyte growth factor receptor modulators
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A